Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 83.76M | $ 3.68M | $ 930K | $ 0 | -5.5% |
3/31/2025 | $ 69.4M | $ 3.21M | $ 0 | $ 0 | -4.63% |
12/31/2024 | $ 82.26M | $ 1.09M | $ 1K | $ 0 | -1.33% |
9/30/2024 | $ 86.87M | $ 93.44M | $ 500 | $ 0 | -107.56% |
6/30/2024 | $ 91.72M | $ 128.4M | $ -784.1K | $ 0 | -139.14% |
3/31/2024 | $ 101.89M | $ 129.39M | $ -985K | $ 0 | -126.03% |
12/31/2023 | $ 132.42M | $ 129.47M | $ -1.3M | $ 0 | -96.79% |
9/30/2023 | $ 78.1M | $ 35.96M | $ -1.61M | $ 0 | -43.98% |
6/30/2023 | $ 70.36M | $ 914K | $ -1.13M | $ 0 | 0.31% |
3/31/2023 | $ 13.54M | $ -6.4K | $ -1.04M | $ 0 | 7.7% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for VISTAGEN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 20.2M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -108.2K ]) / Market Cap [ $ 51.99M ]
(=) Shareholder Yield [ -38.64% ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.38% |
max | 34.45% |
average | 0.59% |
median | 1.08% |
std | 11.11% |